A Phase 1 Study of [225Ac]-FPI-1434 Injection
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)
- Status
- COMPLETED
- Phase
- PHASE3
Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
- Status
- COMPLETED
- Phase
- PHASE2